Acknowledgments
The author would like to thank staff of the Department of Urology in
Sultan Abdulhamid Han Education and Research Hospital.
REFERENCES 1. Siegel RL, Miller KD, Jemal A. Cancer statistics,
2018. CA Cancer J Clin. 2018;68(1):7-30.
2. Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic
intraepithelial neoplasia in needle biopsies. J Urol.1995;154(5):1791-1794.
3. Cheville JC, Reznicek MJ, Bostwick DG. The focus of ”atypical glands,
suspicious for malignancy” in prostatic needle biopsy specimens:
incidence, histologic features, and clinical follow-up of cases
diagnosed in a community practice. Am J Clin Pathol.1997;108(6):633-640.
4. Montironi R, Scattoni V, Mazzucchelli R, Lopez-Beltran A, Bostwick
DG, Montorsi F. Atypical foci suspicious but not diagnostic of
malignancy in prostate needle biopsies (also referred to as ”atypical
small acinar proliferation suspicious for but not diagnostic of
malignancy”). Eur Urol. 2006;50(4):666-674.
5. Srirangam V, Rai BP, Abroaf A, et al. Atypical Small Acinar
Proliferation and High Grade Prostatic Intraepithelial Neoplasia: Should
We Be Concerned? An Observational Cohort Study with a Minimum Follow-Up
of 3 Years. Curr Urol. 2017;10(4):199-205.
6. Leone L, Lacetera V, Montironi R, et al. Biopsy follow-up in patients
with isolated atypical small acinar proliferation (ASAP) in prostate
biopsy. Arch Ital Urol Androl. 2014;86(4):332-335.
7. Carroll PR, Parsons JK, Andriole G, et al. Prostate cancer early
detection, version 1.2014. Featured updates to the NCCN Guidelines.J Natl Compr Canc Netw. 2014;12(9):1211-1219; quiz 1219.
8. Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG Guidelines on
Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with
Curative Intent. Eur Urol. 2017;71(4):618-629.
9. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic
intraepithelial neoplasia or atypical foci suspicious for carcinoma:
implications for patient care. J Urol. 2006;175(3 Pt 1):820-834.
10. Ericson KJ, Wenger HC, Rosen AM, et al. Prostate cancer detection
following diagnosis of atypical small acinar proliferation. Can J
Urol. 2017;24(2):8714-8720.
11. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Is repeat
prostate biopsy associated with a greater risk of hospitalization? Data
from SEER-Medicare. J Urol. 2013;189(3):867-870.
12. Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of
complications of prostate biopsy. Eur Urol. 2013;64(6):876-892.
13. Quaresima L, Lacetera V, Leone L, et al. The impact of repeated
prostate biopsies on sexual function and urinary symptoms in patients
with diagnosis of Atypical Small Acinar Proliferation (ASAP): can
ecoDoppler reduce side effects? Arch Ital Urol Androl.2014;86(4):356-358.
14. Fandella A. Analysis of costs of transrectal prostate biopsy.Urologia. 2011;78(4):288-292.
15. Ynalvez LA, Kosarek CD, Kerr PS, et al. Atypical small acinar
proliferation at index prostate biopsy: rethinking the re-biopsy
paradigm. Int Urol Nephrol. 2018;50(1):1-6.
16. Leone A, Rotker K, Butler C, et al. Atypical Small Acinar
Proliferation: Repeat Biopsy and Detection of High Grade Prostate
Cancer. Prostate Cancer. 2015;2015:810159.
17. Leone A, Gershman B, Rotker K, et al. Atypical small acinar
proliferation (ASAP): Is a repeat biopsy necessary ASAP? A
multi-institutional review. Prostate Cancer Prostatic Dis.2016;19(1):68-71.
18. Mallen E, Gil P, Sancho C, et al. Atypical small acinar
proliferation: review of a series of 64 patients. Scand J Urol
Nephrol. 2006;40(4):272-275.
19. Sakura M, Kawakami S, Ishioka J, et al. A novel repeat biopsy
nomogram based on three-dimensional extended biopsy. Urology.2011;77(4):915-920.
20. Moussa AS, Jones JS, Yu C, Fareed K, Kattan MW. Development and
validation of a nomogram for predicting a positive repeat prostate
biopsy in patients with a previous negative biopsy session in the era of
extended prostate sampling. BJU Int. 2010;106(9):1309-1314.
21. Yanke BV, Gonen M, Scardino PT, Kattan MW. Validation of a nomogram
for predicting positive repeat biopsy for prostate cancer. J
Urol. 2005;173(2):421-424.
22. Lopez-Corona E, Ohori M, Scardino PT, Reuter VE, Gonen M, Kattan MW.
A nomogram for predicting a positive repeat prostate biopsy in patients
with a previous negative biopsy session. J Urol. 2003;170(4 Pt
1):1184-1188; discussion 1188.
23. Scattoni V, Roscigno M, Freschi M, et al. Atypical small acinar
proliferation (ASAP) on extended prostatic biopsies: predictive factors
of cancer detection on repeat biopsies. Arch Ital Urol Androl.2005;77(1):31-36.
24. Chen R, Huang Y, Cai X, et al. Age-Specific Cutoff Value for the
Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese
Men with Serum PSA Levels of 4.0-10.0 ng/ml. PLoS One.2015;10(6):e0130308.